Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation

Bone Marrow Transplantation

Volumn 17, Issue 4, 1996, Pages 543-548

  Kline, R M ^a   Stiehm, E R ^b   Cowan, M J ^c  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone marrow transplantation; Boosts; Haploidentical; SCID; Second transplants; T cell depleted

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN;

APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CELL FUNCTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMAGGLUTINATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOTHERAPY; INFANT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; SURVIVAL TIME; T LYMPHOCYTE;

ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; HAPLOTYPES; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBSETS; MALE; NUCLEAR FAMILY; PARENTS; RETREATMENT; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION CONDITIONING;

EID: 0029926194     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kenny AB, Hitzig WH. Bone marrow transplantation for severe combined immunodeficiency disease. Eur J Paediatr 1979; 131: 155-177.
2. Fischer A, Landais P, Friedrich W et al. European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 1990; 336: 850-854.
3. Stephan JL, Vlekova V, Le Deist F et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993; 123: 564-572.
4. Champlin RE, Ho WG, Nimer SD et al. Bone marrow transplantation for severe aplastic anemia. Transplantation 1990: 49: 720-724.
5. Reisner Y, Kapoor N, Kirkpatrick D et al. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981; ii: 327-331.
6. Reinherz EL, Geha R, Pappeport JM et al. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad SCI USA 1982; 79: 6047-6051.
7. Filipovich AH, Vallera DA. Youle RJ et al. Ex vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease Lancet 1984; i: 469-472.
8. Morgan G, Linen DC, Knott LT et al. Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-I monoclonal antibody and E-rosetting. Br J Haematol 1986; 62: 421-430.
9. Fischer A, Griscelli C, Friedrich W et al. Bone marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985. Lancet 1986; ii: 1080-1084.
10. Cowan MJ, Wara DW, Weintrub PS et al. Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells. J Clin Immunol 1985; 5: 370-376.
11. Dror Y, Gallagher R, Wara DW et al. Immune reconstitution in severe combined immunodeficiency disease after lectin treated, T cell depleted haplocompatible bone marrow transplantation. Blood 1993; 81: 2021-2030.
12. Keman NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donor facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
13. Anasetti C, Beatty PG, Storb R et al. Effect of HLA incompatibility on graft-versus-host-disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990; 29: 79-91.
14. Sondel PM, Bozdech MJ, Trigg ME et al. Additional immuno-suppression allows engraftment following HLA-mismatched T cell-depleted bone marrow transplantation for leukemia. Trans Proc 1985; XVII: 462-464.
15. Murphy S, Hayward A, Troup G et al. Genetic enrichment in an American Indian population: an excess of severe combined immunodeficiency disease. Lancet 1980; 2: 502-505.
16. Mitsuyasu RT, Champlin RE, Gale RP et al. Treatment of donor bone marrow with monoclonal anti-T cell antibody and complement for prevention of graft-versus-host-disease. Ann Intern Med 1986; 105: 20-26.
17. + Leu 8+ T cell supernatant activity that inhibits Ig production. J Immunol 1991; 147: 155-161.
18. Cowan MJ, Fujiwara P, Ammann AJ. Cellular immune defect in selective IgA deficiency using a microculture method for PHA stimulation and limiting dilution. Clin Immunol Immunopathol 1980; 17: 595-605.
19. Snedcor G, Cochran W. The comparison of two samples. Statistical Methods. Iowa State University Press: Ames, Iowa, 1967, pp 104-105.
20. Daley JP, Rozans MK, Smith BR et al. Retarded recovery of functional T cell frequencies in T cell depleted bone marrow transplant recipients. Blood 1987, 70: 960-964.
21. Butturini A, Gale RP. T cell depletion in bone marrow transplantation for leukemia: current results and future directions. Bone Marrow Transplant 1988; 3; 185-192.
22. Laporte JP, Lesage S, Douay L et al. Allogeneic transplantation with peripheral blood hematopoietic precursors mobilized with G-CSF. Blood 1994; 84 (Suppl. 1): 90a (abstr. no. 347).
23. Maiolino I, Buscemi F, Scime R et al. G-CSF mobilized PBSC for allogeneic transplantation. Blood 1994; 84 (Suppl. 1): 92a (abstr. no. 358).